Basic ctDNA Panel Promises Affordable Clinical Validity in Colon Cancer Patients but Not in Pancreas Cancer Patients

The potential of circulating tumor DNA (ctDNA) as a biomarker to assess the progression of various solid tumors has been explored extensively. In this study, we investigated the feasibility of utilizing a ctDNA sequencing panel specifically designed to target the most frequently mutated genomic regi...

Full description

Bibliographic Details

Published in:	Life
Main Authors:	Mandy Radefeldt, Silke Stellmacher-Kaiser, Susann Krake, Brigitte Kragl, Sabrina Lemke, Christian Beetz, Peter Bauer, Christian Junghanß, Ruslan Al-Ali
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Subjects:	ctDNA cancer colon pancreas panel biomarker
Online Access:	https://www.mdpi.com/2075-1729/13/12/2274